These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10594034)

  • 1. Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy.
    Okuda T; Takeda K; Fujita Y; Nishimura M; Yagyu S; Yoshida M; Akira S; Downing JR; Abe T
    Mol Cell Biol; 2000 Jan; 20(1):319-28. PubMed ID: 10594034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development.
    Nishimura M; Fukushima-Nakase Y; Fujita Y; Nakao M; Toda S; Kitamura N; Abe T; Okuda T
    Blood; 2004 Jan; 103(2):562-70. PubMed ID: 14504086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region.
    Goyama S; Yamaguchi Y; Imai Y; Kawazu M; Nakagawa M; Asai T; Kumano K; Mitani K; Ogawa S; Chiba S; Kurokawa M; Hirai H
    Blood; 2004 Dec; 104(12):3558-64. PubMed ID: 15271791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
    Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.
    Okuda T; van Deursen J; Hiebert SW; Grosveld G; Downing JR
    Cell; 1996 Jan; 84(2):321-30. PubMed ID: 8565077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
    Miller JD; Stacy T; Liu PP; Speck NA
    Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors.
    Okuda T; Cai Z; Yang S; Lenny N; Lyu CJ; van Deursen JM; Harada H; Downing JR
    Blood; 1998 May; 91(9):3134-43. PubMed ID: 9558367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms.
    Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Shibata Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():299-302. PubMed ID: 9209372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF - a model for overcoming inhibition of proliferation by CBF oncoproteins.
    Lou J; Cao W; Bernardin F; Ayyanathan K; RauscherIII FJ; Friedman AD
    Oncogene; 2000 May; 19(22):2695-703. PubMed ID: 10851069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor.
    Niki M; Okada H; Takano H; Kuno J; Tani K; Hibino H; Asano S; Ito Y; Satake M; Noda T
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5697-702. PubMed ID: 9159135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells.
    Zhang YW; Bae SC; Huang G; Fu YX; Lu J; Ahn MY; Kanno Y; Kanno T; Ito Y
    Mol Cell Biol; 1997 Jul; 17(7):4133-45. PubMed ID: 9199349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
    Peterson LF; Lo MC; Okumura AJ; Zhang DE
    Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation.
    Imai Y; Kurokawa M; Tanaka K; Friedman AD; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Biochem Biophys Res Commun; 1998 Nov; 252(3):582-9. PubMed ID: 9837750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
    Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
    Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo.
    Cai Z; de Bruijn M; Ma X; Dortland B; Luteijn T; Downing RJ; Dzierzak E
    Immunity; 2000 Oct; 13(4):423-31. PubMed ID: 11070161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
    Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the AML1 transcription factor in leukemogenesis.
    Lorsbach RB; Downing JR
    Int J Hematol; 2001 Oct; 74(3):258-65. PubMed ID: 11721960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region.
    Mukouyama Y; Chiba N; Hara T; Okada H; Ito Y; Kanamaru R; Miyajima A; Satake M; Watanabe T
    Dev Biol; 2000 Apr; 220(1):27-36. PubMed ID: 10720428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos.
    Maki K; Yamagata T; Asai T; Yamazaki I; Oda H; Hirai H; Mitani K
    Blood; 2005 Sep; 106(6):2147-55. PubMed ID: 15914564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.